Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
41.29 EUR | -0.31% |
|
-1.81% | +20.31% |
06:51pm | Markel Insurance Appoints Chelsea Jiang as Managing Director Greater China | CI |
15/07 | AXA : UBS keeps its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.43 | 0.77 | 0.79 | 0.9 | 1.01 | |||||
Return on Total Capital | 2.32 | 4.12 | 4.45 | 4.85 | 5.39 | |||||
Return On Equity % | 3.95 | 8.92 | 9.95 | 12.77 | 12.47 | |||||
Return on Common Equity | 4.22 | 9.95 | 11.15 | 14.64 | 14.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.26 | 16.88 | 18.79 | 15.14 | 14.49 | |||||
SG&A Margin | 9.54 | 8.5 | 10 | - | - | |||||
EBITDA Margin % | 5.89 | 8.68 | 9.84 | - | - | |||||
EBITA Margin % | 5 | 8.17 | 9.13 | 10.75 | 11.45 | |||||
EBIT Margin % | 4.85 | 7.97 | 9 | 10.62 | 11.45 | |||||
Income From Continuing Operations Margin % | 2.96 | 6.15 | 6.61 | 8.46 | 8.24 | |||||
Net Income Margin % | 2.82 | 5.97 | 6.44 | 8.25 | 8.64 | |||||
Net Avail. For Common Margin % | 2.66 | 5.81 | 6.26 | 8.04 | 7.81 | |||||
Normalized Net Income Margin | 2.61 | 4.64 | 5.08 | 6.19 | 6.65 | |||||
Levered Free Cash Flow Margin | 2.4 | 5.24 | 2.25 | 3.49 | 5.48 | |||||
Unlevered Free Cash Flow Margin | 2.88 | 5.48 | 2.53 | 3.92 | 5.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.14 | 0.15 | 0.14 | 0.14 | 0.14 | |||||
Fixed Assets Turnover | 40.69 | 47.99 | 44.37 | 40.29 | 42.38 | |||||
Receivables Turnover (Average Receivables) | 4.89 | 5.13 | 5.17 | 10.5T | 10.29T | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.6 | 0.56 | 0.59 | 1.89 | 1.93 | |||||
Quick Ratio | 0.27 | 0.28 | 0.27 | 1.16 | 1.26 | |||||
Operating Cash Flow to Current Liabilities | 0.12 | 0.03 | 0.04 | 0.09 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 74.83 | 71.09 | 70.57 | 0.03 | 0.04 | |||||
Average Days Payable Outstanding | 419.24 | 418.37 | 534.28 | 0.03 | 0.03 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 76.81 | 73.75 | 115.73 | 99.25 | 102.5 | |||||
Total Debt / Total Capital | 43.44 | 42.45 | 53.65 | 49.81 | 50.62 | |||||
LT Debt/Equity | 35.27 | 36.72 | 54.39 | 40.12 | 40.52 | |||||
Long-Term Debt / Total Capital | 19.95 | 21.14 | 25.21 | 20.14 | 20.01 | |||||
Total Liabilities / Total Assets | 89.39 | 89.3 | 92.14 | 90.69 | 90.73 | |||||
EBIT / Interest Expense | 6.2 | 21.07 | 19.58 | 15.2 | 17.21 | |||||
EBITDA / Interest Expense | 7.54 | 22.95 | 21.4 | - | - | |||||
(EBITDA - Capex) / Interest Expense | 7.1 | 22.19 | 20.66 | - | - | |||||
Total Debt / EBITDA | 9.91 | 5.77 | 6.21 | - | - | |||||
Net Debt / EBITDA | 5.64 | 3.41 | 3.65 | - | - | |||||
Total Debt / (EBITDA - Capex) | 10.52 | 5.97 | 6.43 | - | - | |||||
Net Debt / (EBITDA - Capex) | 5.99 | 3.53 | 3.78 | - | - | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -15.6 | 8.74 | -15.12 | 0.41 | 6.46 | |||||
Gross Profit, 1 Yr. Growth % | -7.47 | 28.72 | -5.48 | 17.22 | 12.44 | |||||
EBITDA, 1 Yr. Growth % | -9.7 | 60.14 | -3.73 | - | - | |||||
EBITA, 1 Yr. Growth % | -7.98 | 77.72 | -5.12 | 24.12 | 18.23 | |||||
EBIT, 1 Yr. Growth % | -8.58 | 78.75 | -4.06 | 24.8 | 18.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -20.8 | 125.4 | -8.7 | 41.6 | 6.86 | |||||
Net Income, 1 Yr. Growth % | -17.97 | 130.53 | -8.49 | 42.05 | 9.7 | |||||
Normalized Net Income, 1 Yr. Growth % | -10.02 | 93.17 | -7.04 | 35.23 | 18.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -17.77 | 137.6 | -4.71 | 47.64 | 8.99 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.8 | -7.78 | -8.68 | -6.1 | 5.58 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.27 | -1.21 | 4.73 | 175 | -54.55 | |||||
Total Assets, 1 Yr. Growth % | 3.04 | -3.62 | -10.16 | 0.95 | 1.46 | |||||
Common Equity, 1 Yr. Growth % | 2.45 | -0.66 | -36.24 | 7.61 | 0.73 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.09 | -1.83 | -53.08 | 14.34 | 1.03 | |||||
Cash From Operations, 1 Yr. Growth % | 189.27 | -74.44 | 20.76 | -26.05 | 197.54 | |||||
Capital Expenditures, 1 Yr. Growth % | -15.8 | -10.03 | 0.86 | 7.29 | 13.6 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 3.86 | 137.88 | -63.61 | -102.06 | 85.8 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 6.54 | 106.51 | -60.72 | -102.33 | 75.06 | |||||
Dividend Per Share, 1 Yr. Growth % | 95.89 | 7.69 | 10.39 | 16.47 | 8.59 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.74 | -4.2 | -3.93 | -15.54 | 2.54 | |||||
Gross Profit, 2 Yr. CAGR % | -8.96 | 9.13 | 10.3 | -20.01 | 8.39 | |||||
EBITDA, 2 Yr. CAGR % | -14.15 | 20.26 | 24.17 | - | - | |||||
EBITA, 2 Yr. CAGR % | -17.52 | 27.88 | 29.85 | -3.12 | 17.65 | |||||
EBIT, 2 Yr. CAGR % | -18.19 | 27.83 | 30.96 | -2.49 | 18.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 678.23 | 33.61 | 43.46 | -0.9 | 20.17 | |||||
Net Income, 2 Yr. CAGR % | 21.59 | 37.52 | 45.25 | -0.72 | 24.83 | |||||
Normalized Net Income, 2 Yr. CAGR % | -37.12 | 31.83 | 34 | -2.47 | 23.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 13.65 | 39.78 | 50.47 | 2.66 | 23.77 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 28.71 | -7.79 | -8.23 | -7.4 | -0.43 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.29 | -2.25 | 1.72 | -97.72 | 11.8 | |||||
Total Assets, 2 Yr. CAGR % | -7.02 | -0.35 | -6.95 | -8.84 | 1.2 | |||||
Common Equity, 2 Yr. CAGR % | 7.1 | 0.88 | -20.42 | -16.52 | 4.12 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.61 | 2.53 | -32.13 | -25.59 | 7.48 | |||||
Cash From Operations, 2 Yr. CAGR % | 82.89 | -14.02 | -44.44 | -0.68 | 16.81 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.24 | -12.96 | -4.74 | 10.45 | 9.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -69.67 | 57.18 | -6.95 | -31.11 | -81.58 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -66.92 | 48.32 | -9.94 | -28.51 | -80.87 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.3 | 45.24 | 9.03 | 13.39 | 12.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.37 | 4.71 | -7.99 | -8.12 | -9.27 | |||||
Gross Profit, 3 Yr. CAGR % | -4.62 | 2.18 | 4.03 | -6.26 | -13.77 | |||||
EBITDA, 3 Yr. CAGR % | -6.73 | 5.68 | 11.66 | - | - | |||||
EBITA, 3 Yr. CAGR % | -10.51 | 6.53 | 15.77 | 18.6 | 1.54 | |||||
EBIT, 3 Yr. CAGR % | -11.02 | 6.16 | 16.17 | 19.34 | 2.39 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -20.39 | 414.9 | 17.68 | 30.32 | 0.05 | |||||
Net Income, 3 Yr. CAGR % | -20.13 | 50.49 | 20.06 | 31.47 | 2.64 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.68 | -8.6 | 17.34 | 22.48 | 2.3 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -20.52 | 45.33 | 23.02 | 35.79 | 3.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 24.28 | 15.18 | -8.08 | -7.52 | -3.26 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16.52 | 1.76 | 0.03 | -91.99 | -93.82 | |||||
Total Assets, 3 Yr. CAGR % | -2.58 | -5.9 | -3.73 | -7.13 | -5.53 | |||||
Common Equity, 3 Yr. CAGR % | 0.95 | 4.45 | -13.43 | -11.53 | -11.12 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.3 | 6.94 | -20.99 | -18.39 | -17.6 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.61 | -5.09 | -3.71 | -36.83 | 22.1 | |||||
Capital Expenditures, 3 Yr. CAGR % | -0.34 | -8.84 | -8.58 | 3.16 | 10.79 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -32.95 | -39.74 | -3.48 | 4.13 | -7.89 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -29.19 | -39.09 | -4.75 | 1.81 | -7 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.31 | 4.75 | 32.55 | 11.46 | 11.76 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.54 | -0.78 | -4.8 | -3.92 | -7.27 | |||||
Gross Profit, 5 Yr. CAGR % | -3 | 1.19 | 1.09 | -7.35 | -5.25 | |||||
EBITDA, 5 Yr. CAGR % | -5.51 | 1.54 | 4.58 | - | - | |||||
EBITA, 5 Yr. CAGR % | -7.09 | 1.5 | 3.86 | 2.56 | 11.35 | |||||
EBIT, 5 Yr. CAGR % | -7.39 | 1.24 | 3.85 | 2.61 | 11.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -10.87 | 2.51 | 0.75 | 166.35 | 12.32 | |||||
Net Income, 5 Yr. CAGR % | -10.84 | 4.59 | 1.46 | 27.42 | 15.38 | |||||
Normalized Net Income, 5 Yr. CAGR % | -8 | 1.34 | 3.63 | -6.19 | 13.22 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -10.28 | 3.67 | 2.59 | 26.46 | 16.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.09 | 10.06 | 10.08 | 5.55 | -5.09 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.16 | 10.48 | 10.36 | -77.72 | -81.34 | |||||
Total Assets, 5 Yr. CAGR % | -1.93 | -2.78 | -4.35 | -7.09 | -3.49 | |||||
Common Equity, 5 Yr. CAGR % | 0.9 | 0.15 | -8.21 | -4.5 | -6.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1 | -0.39 | -14.51 | -7.5 | -10.07 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.98 | -13.58 | -13.76 | -3.35 | 6.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.38 | -5.81 | -2.12 | -1.56 | 0.6 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.92 | 30.99 | -23.56 | -36.42 | 14.06 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 0.74 | 29.39 | -22.04 | -35.06 | 12.09 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.39 | 5.83 | 6.17 | 8.12 | 24.11 |
- Stock Market
- Equities
- CS Stock
- Financials AXA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition